A Fifth Circuit ruling that the FDA acted improperly in its regulation of mifepristone is unlikely to have much impact on access to medication abortion, says Dean Rachel Rebouche.
Published on August 17, 2023
What To Know About The Latest Court Ruling On The Abortion Pill
